On September 14, 2023, Aprogen Medicines Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,055 KRW | -12.74% | -19.10% | +9.90% |
14/05 | Aprogen Medicines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
19/03 | Aprogen Medicines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+9.90% | 193M | |
-13.59% | 10.69B | |
+11.48% | 5.83B | |
-27.35% | 2.03B | |
-22.48% | 1.42B | |
+3.97% | 1.13B | |
-21.24% | 753M | |
-47.86% | 680M | |
-5.69% | 610M | |
-5.92% | 479M |
- Stock Market
- Equities
- A007460 Stock
- News Aprogen Medicines Inc.
- Aprogen Medicines Inc. announced that it has received KRW 70 billion in funding